Detalhe da pesquisa
1.
Targeted therapy in Burkitt lymphoma: Small molecule inhibitors under investigation.
Br J Haematol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577716
2.
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
Br J Haematol
; 204(1): 160-170, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881141
3.
How I treat cardiovascular complications in patients with lymphoid malignancies.
Blood
; 139(10): 1501-1516, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34752600
4.
Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.
Haematologica
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235513
5.
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Am J Hematol
; 99(3): 408-421, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217361
6.
Physical activity and the risk of non-Hodgkin lymphoma subtypes: A pooled analysis.
Int J Cancer
; 152(3): 396-407, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054546
7.
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031804
8.
Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma.
Hematol Oncol
; 41(1): 39-49, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305717
9.
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hematol Oncol
; 41(4): 644-654, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254453
10.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw
; 21(11): 1118-1131, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935098
11.
A roadmap for clinical trial design in marginal zone lymphoma.
Am J Hematol
; 97(11): 1398-1403, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030403
12.
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma.
Am J Hematol
; 97(12): 1529-1537, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057138
13.
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018).
Am J Hematol
; 97(9): 1150-1158, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713565
14.
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
Am J Hematol
; 97(4): 401-410, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015310
15.
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma.
Int J Cancer
; 149(3): 535-545, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33644854
16.
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.
Am J Transplant
; 21(2): 460-474, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969590
17.
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
Am J Transplant
; 21(2): 475-483, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976703
18.
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 195(2): 210-216, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340248
19.
Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma.
Blood
; 134(16): 1289-1297, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350266
20.
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
Hematol Oncol
; 39(5): 658-663, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453851